SCHEMBL23036732

SCHEMBL23036732

COc1ncccc1[C@@H]1CCCCCN1C=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
MAPT P10636 2/20 0.39
PDE10A Q9Y233 1/20 0.37
KDM4E B2RXH2 1/20 0.36
FAAH O00519 1/20 0.35
HTR1A P08908 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
C3AR1 Q16581 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23036723 0.83 ALDH1A1 (0.37) CHRNB4CHRNA3MAPTKDM4EALDH1A1
SCHEMBL29456354 0.83 ALDH1A1 (0.37) CHRNB4CHRNA3MAPTKDM4EALDH1A1
SCHEMBL21491399 0.83 ALDH1A1 (0.37) CHRNB4CHRNA3MAPTKDM4EALDH1A1
SCHEMBL23036803 0.80 CYP2C19 (0.38) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL21491440 0.80 CYP2C19 (0.38) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL29456344 0.80 CYP2C19 (0.38) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL20472385 0.76 CHRNB4 (0.56) CHRNB4CHRNA3MAPTALDH1A1CHRNB2
SCHEMBL5263045 0.73 SIGMAR1 (0.42) MAPTALDH1A1GAASIGMAR1LMNA
SCHEMBL28975866 0.72 PRMT5 (0.43) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL23036733 0.72 KMT2A (0.36) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3784666-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF Merck Patent GmbH (DE) 2021-03-03 EP disclosed